| Drug-Target Information | ||||||||
|---|---|---|---|---|---|---|---|---|
| Drug Name | Target Name | Drug Type | Target Type | Source | Drug MeSHID | Interaction Score | Drug Status | Target Action |
| calcium | alkaline phosphatase, placental type | small molecule | NA | drugbank | Signal Transduction Pathways[MeSHID:D015398] Bone Tissue[MeSHID:D001842] Cells[MeSHID:D002477] Osteoporosis[MeSHID:D010024] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | nutraceutical | unknown |
| calcium | amiloride-sensitive amine oxidase [copper-containing] | small molecule | NA | drugbank | Signal Transduction Pathways[MeSHID:D015398] Bone Tissue[MeSHID:D001842] Cells[MeSHID:D002477] Osteoporosis[MeSHID:D010024] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | nutraceutical | unknown |
| calcium | calcium-transporting atpase type 2c member 1 | small molecule | NA | drugbank | Signal Transduction Pathways[MeSHID:D015398] Bone Tissue[MeSHID:D001842] Cells[MeSHID:D002477] Osteoporosis[MeSHID:D010024] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | nutraceutical | agonist |
| calcium | bone morphogenetic protein 4 | small molecule | NA | drugbank | Signal Transduction Pathways[MeSHID:D015398] Bone Tissue[MeSHID:D001842] Cells[MeSHID:D002477] Osteoporosis[MeSHID:D010024] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | nutraceutical | unknown |
| calcium | voltage-dependent l-type calcium channel subunit alpha-1c | small molecule | NA | drugbank | Signal Transduction Pathways[MeSHID:D015398] Bone Tissue[MeSHID:D001842] Cells[MeSHID:D002477] Osteoporosis[MeSHID:D010024] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | nutraceutical | ligand |
| calcium | calmodulin | small molecule | NA | drugbank | Signal Transduction Pathways[MeSHID:D015398] Bone Tissue[MeSHID:D001842] Cells[MeSHID:D002477] Osteoporosis[MeSHID:D010024] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | nutraceutical | unknown |
| calcium | calpastatin | small molecule | NA | drugbank | Signal Transduction Pathways[MeSHID:D015398] Bone Tissue[MeSHID:D001842] Cells[MeSHID:D002477] Osteoporosis[MeSHID:D010024] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | nutraceutical | unknown |
| calcium | cartilage oligomeric matrix protein | small molecule | NA | drugbank | Signal Transduction Pathways[MeSHID:D015398] Bone Tissue[MeSHID:D001842] Cells[MeSHID:D002477] Osteoporosis[MeSHID:D010024] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | nutraceutical | unknown |
| calcium | ceruloplasmin | small molecule | NA | drugbank | Signal Transduction Pathways[MeSHID:D015398] Bone Tissue[MeSHID:D001842] Cells[MeSHID:D002477] Osteoporosis[MeSHID:D010024] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | nutraceutical | unknown |
| calcium | matrix gla protein | small molecule | NA | drugbank | Signal Transduction Pathways[MeSHID:D015398] Bone Tissue[MeSHID:D001842] Cells[MeSHID:D002477] Osteoporosis[MeSHID:D010024] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | nutraceutical | unknown |
| calcium | protocadherin-19 | small molecule | NA | drugbank | Signal Transduction Pathways[MeSHID:D015398] Bone Tissue[MeSHID:D001842] Cells[MeSHID:D002477] Osteoporosis[MeSHID:D010024] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | nutraceutical | unknown |
| calcium | programmed cell death protein 6 | small molecule | NA | drugbank | Signal Transduction Pathways[MeSHID:D015398] Bone Tissue[MeSHID:D001842] Cells[MeSHID:D002477] Osteoporosis[MeSHID:D010024] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | nutraceutical | unknown |
| calcium | protein s100-a13 | small molecule | NA | drugbank | Signal Transduction Pathways[MeSHID:D015398] Bone Tissue[MeSHID:D001842] Cells[MeSHID:D002477] Osteoporosis[MeSHID:D010024] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | nutraceutical | unknown |
| calcium | protein s100-a2 | small molecule | NA | drugbank | Signal Transduction Pathways[MeSHID:D015398] Bone Tissue[MeSHID:D001842] Cells[MeSHID:D002477] Osteoporosis[MeSHID:D010024] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | nutraceutical | unknown |
| calcium | protein s100-a8 | small molecule | NA | drugbank | Signal Transduction Pathways[MeSHID:D015398] Bone Tissue[MeSHID:D001842] Cells[MeSHID:D002477] Osteoporosis[MeSHID:D010024] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | nutraceutical | unknown |
| calcium | protein s100-a9 | small molecule | NA | drugbank | Signal Transduction Pathways[MeSHID:D015398] Bone Tissue[MeSHID:D001842] Cells[MeSHID:D002477] Osteoporosis[MeSHID:D010024] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | nutraceutical | unknown |
| calcium | protein s100-b | small molecule | NA | drugbank | Signal Transduction Pathways[MeSHID:D015398] Bone Tissue[MeSHID:D001842] Cells[MeSHID:D002477] Osteoporosis[MeSHID:D010024] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | nutraceutical | unknown |
| calcium | spectrin beta chain, non-erythrocytic 1 | small molecule | NA | drugbank | Signal Transduction Pathways[MeSHID:D015398] Bone Tissue[MeSHID:D001842] Cells[MeSHID:D002477] Osteoporosis[MeSHID:D010024] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | nutraceutical | agonist |
| calcium | troponin c, slow skeletal and cardiac muscles | small molecule | NA | drugbank | Signal Transduction Pathways[MeSHID:D015398] Bone Tissue[MeSHID:D001842] Cells[MeSHID:D002477] Osteoporosis[MeSHID:D010024] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | nutraceutical | agonist |
| calcium | troponin c, skeletal muscle | small molecule | NA | drugbank | Signal Transduction Pathways[MeSHID:D015398] Bone Tissue[MeSHID:D001842] Cells[MeSHID:D002477] Osteoporosis[MeSHID:D010024] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | nutraceutical | agonist |
| click here to return to the previous page | ||||||||